|
🦁
|
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
15 auth.
M. Peters,
H. Hann,
Paul L. Martin,
E. Heathcote,
P. Buggisch,
R. Rubin,
M. Bourliere,
K. Kowdley,
C. Trépo,
D. Gray,
...
M. Sullivan,
K. Kleber,
R. Ebrahimi,
S. Xiong,
C. Brosgart
|
9 |
2004 |
9
🦁
|
|
🐜
|
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
31 auth.
R. Chung,
M. Ghany,
A. Kim,
K. Marks,
S. Naggie,
H. Vargas,
A. Aronsohn,
D. Bhattacharya,
Tina Broder,
Oluwaseun O Falade-Nwulia,
R. Fontana,
S. Gordon,
T. Heller,
S. Holmberg,
R. Jhaveri,
...
M. Jonas,
J. Kiser,
B. Linas,
V. Lo Re,
T. Morgan,
R. Nahass,
M. Peters,
K. Reddy,
A. Reynolds,
John D. Scott,
Gloria Searson,
T. Swan,
N. Terrault,
S. Trooskin,
J. Wong,
K. Workowski
|
9 |
2018 |
9
🐜
|
|
🐜
|
Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis
11 auth.
F. Yao,
R. Kerlan,
R. Hirose,
T. Davern,
N. Bass,
S. Feng,
...
M. Peters,
N. Terrault,
C. Freise,
N. Ascher,
J. Roberts
|
9 |
2008 |
9
🐜
|
|
🐜
|
Hepatitis B virus infection
8 auth.
M. Yuen,
Ding‐Shinn Chen,
G. Dusheiko,
H. Janssen,
D. Lau,
S. Locarnini,
...
M. Peters,
Ching‐lung Lai
|
8 |
2018 |
8
🐜
|
|
🐜
|
Psychiatric complications of long-term interferon alfa therapy.
8 auth.
P. Renault,
J. Hoofnagle,
Y. Park,
K. Mullen,
M. Peters,
D. Jones,
...
V. Rustgi,
E. Jones
|
8 |
1987 |
8
🐜
|
|
🐜
|
Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
10 auth.
J. Hoofnagle,
M. Peters,
K. Mullen,
D. Jones,
V. Rustgi,
A. D. Di Bisceglie,
...
C. Hallahan,
Y. Park,
C. Meschievitz,
E. Jones
|
8 |
1988 |
8
🐜
|
|
🐜
|
A global scientific strategy to cure hepatitis B.
51 auth.
P. Revill,
F. Chisari,
Joan M. Block,
M. Dandri,
A. Gehring,
Haitao Guo,
Jianming Hu,
A. Kramvis,
P. Lampertico,
H. Janssen,
M. Levrero,
Wenhui Li,
T. Liang,
S. Lim,
F. Lu,
...
M. Penicaud,
J. Tavis,
R. Thimme,
F. Zoulim,
P. Arbuthnot,
A. Boonstra,
K.‐M. Chang,
Per-Jei Chen,
D. Glebe,
L. Guidotti,
J. Fellay,
C. Ferrari,
L. Jansen,
Daryl T. Y. Lau,
Anna S.F. Lok,
M. Maini,
W. Mason,
G. Matthews,
D. Paraskevis,
J. Petersen,
B. Rehermann,
E. Shin,
A. Thompson,
F. van Bömmel,
Fu-sheng Wang,
Koichi Watashi,
Hung‐Chih Yang,
Zhenghong Yuan,
Man-Fung Yuen,
Tim Block,
V. Miller,
U. Protzer,
C. Bréchot,
S. Locarnini,
M. Peters,
R. Schinazi
|
8 |
2019 |
8
🐜
|
|
🐜
|
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
11 auth.
V. Soriano,
M. Puoti,
M. Sulkowski,
A. Cargnel,
Y. Benhamou,
M. Peters,
...
S. Mauss,
N. Bräu,
A. Hatzakis,
S. Pol,
J. Rockstroh
|
8 |
2007 |
8
🐜
|
|
🐜
|
A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
22 auth.
B. Combes,
R. Carithers,
W. Maddrey,
D. Lin,
M. McDonald,
D. Wheeler,
E. Eigenbrodt,
S. Munoz,
R. Rubin,
G. Garcia‐Tsao,
...
G. Bonner,
A. West,
J. Boyer,
V. Luketic,
M. Shiffman,
A. Mills,
M. Peters,
H. White,
R. Zetterman,
S. Rossi,
A. Hofmann,
R. Markin
|
8 |
1993 |
8
🐜
|
|
🐢
|
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
J. Guy,
M. Peters
|
7 |
2013 |
7
🐢
|
|
🐜
|
Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
11 auth.
S. Teefey,
Charles C Hildeboldt,
F. Dehdashti,
B. Siegel,
M. Peters,
J. Heiken,
...
Jeffrey J. Brown,
E. McFarland,
W. Middleton,
D. Balfe,
J. Ritter
|
7 |
2003 |
7
🐜
|
|
🐬
|
New therapies for hepatitis C virus infection.
V. Soriano,
M. Peters,
S. Zeuzem
|
7 |
2009 |
7
🐬
|
